Form 8-K - Current report:
SEC Accession No. 0001641172-25-001519
Filing Date
2025-03-31
Accepted
2025-03-31 09:30:08
Documents
16
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43062
2 ex99-1.htm EX-99.1 80857
3 ex99-1_001.jpg GRAPHIC 15843
  Complete submission text file 0001641172-25-001519.txt   383183

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE biaf-20250331.xsd EX-101.SCH 3785
5 XBRL DEFINITION FILE biaf-20250331_def.xml EX-101.DEF 30033
6 XBRL LABEL FILE biaf-20250331_lab.xml EX-101.LAB 36673
7 XBRL PRESENTATION FILE biaf-20250331_pre.xml EX-101.PRE 27056
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5813
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 25789312
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)